Categories: Reuters

EU places China’s Zhejiang Huahai under increased supervision

(Reuters) – European authorities are placing Zhejiang Huahai Pharmaceutical Co Ltd under higher supervision, the European Medicines Agency said on Monday, in the latest crackdown on the Chinese firm after a probable carcinogen was found in its blood pressure drug valsartan.

EU authorities will now supervise the manufacture of other active substances produced by Zhejiang Huahai more closely, the regulator said on Monday.

European authorities said late last month they had found that Huahai did not comply with good manufacturing practices and that the company’s factory in Linhai, China, was no longer authorized to produce valsartan.

The bulk manufacturer of the high blood pressure drug recalled the product in the United States in July after an impurity linked to cancer was detected.

European and North American regulators last month found a second toxin in Valsartan that may cause cancer in humans.

The review was extended to other ‘sartan’ medicines, including candesartan, irbesartan, losartan, olmesartan and valsartan, after very low levels of a carcinogen was found in losartan made by Hetero Labs in India.

EMA said on Monday low levels of a carcinogen have now also been found in irbesartan made by Aurobindo Pharma, with the supply in the EU of medicines containing irbesartan in EU being suspended.

National authorities in the EU are currently considering whether to recall medicines containing Aurobindo Pharma’s irbesartan from pharmacies as a precaution, the regulator said https://www.ema.europa.eu/en/news/eu-authorities-take-further-action-ongoing-review-sartans-zheijiang-huahai-placed-under-increased.

(Reporting by Ankur Banerjee in Bengaluru; Editing by Sai Sachin Ravikumar and Shailesh Kuber)

Reuters

Recent Posts

  • Reuters

CDC reports 71 new measles cases in a week

(Reuters) - The U.S. Centers for Disease Control and Prevention (CDC) on Monday reported https://www.cdc.gov/measles/cases-outbreaks.html 71 more cases of measles…

8 mins ago
  • Reuters

Merck’s Keytruda wins FDA approval as combination therapy for kidney cancer

(Reuters) - The U.S. Food and Drug Administration has approved Merck & Co Inc's cancer therapy, Keytruda, as part of…

3 hours ago
  • Reuters

China finds more cases of African swine fever on Hainan island

BEIJING (Reuters) - China has detected new cases of African swine fever in six farms across four locations in Hainan…

1 day ago
  • Reuters

China draws up tighter rules on human gene and embryo trials: Xinhua

BEIJING (Reuters) - China's top legislature will consider tougher rules on research involving human genes and embryos, the first such…

2 days ago
  • Reuters

Second death in Novartis gene therapy trials under investigation

By Deena Beasley (Reuters) - Novartis AG, which this week announced positive interim trial results for its experimental gene therapy…

3 days ago
  • Reuters

Higher state minimum wage tied to lower suicide rates

By Lisa Rapaport (Reuters Health) - Suicide rates grow more slowly in states that increase their minimum wage, according to…

3 days ago